Ameriprise’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Sell |
155,495
-5,043
| -3% | -$41.1K | ﹤0.01% | 3146 |
|
|
2025
Q1 | $1.26M | Sell |
160,538
-1,387,053
| -90% | -$10.9M | ﹤0.01% | 3086 |
|
|
2024
Q4 | $23M | Buy |
1,547,591
+228,325
| +17% | +$3.4M | 0.01% | 1239 |
|
|
2024
Q3 | $20.2M | Sell |
1,319,266
-155,172
| -11% | -$2.37M | 0.01% | 1328 |
|
|
2024
Q2 | $22.5M | Buy |
1,474,438
+273,417
| +23% | +$4.16M | 0.01% | 1204 |
|
|
2024
Q1 | $22.7M | Sell |
1,201,021
-433,784
| -27% | -$8.19M | 0.01% | 1230 |
|
|
2023
Q4 | $31.2M | Buy |
1,634,805
+54,881
| +3% | +$1.05M | 0.01% | 1006 |
|
|
2023
Q3 | $28.4M | Buy |
1,579,924
+101,928
| +7% | +$1.83M | 0.01% | 1017 |
|
|
2023
Q2 | $30M | Buy |
1,477,996
+1,282,961
| +658% | +$26.1M | 0.01% | 1022 |
|
|
2023
Q1 | $3.56M | Sell |
195,035
-9,067
| -4% | -$165K | ﹤0.01% | 2542 |
|
|
2022
Q4 | $4.22M | Sell |
204,102
-4,956
| -2% | -$103K | ﹤0.01% | 2411 |
|
|
2022
Q3 | $5.47M | Buy |
209,058
+16,665
| +9% | +$436K | ﹤0.01% | 2150 |
|
|
2022
Q2 | $4.88M | Buy |
+192,393
| New | +$4.88M | ﹤0.01% | 2298 |
|
|
2021
Q4 | – | Sell |
-298,410
| Closed | -$10.4M | – | 4031 |
|
|
2021
Q3 | $10.4M | Hold |
298,410
| – | – | ﹤0.01% | 1823 |
|
|
2021
Q2 | $8.2M | Sell |
298,410
-1,071,985
| -78% | -$29.4M | ﹤0.01% | 2087 |
|
|
2021
Q1 | $38.5M | Sell |
1,370,395
-5,998
| -0.4% | -$168K | 0.01% | 896 |
|
|
2020
Q4 | $35.7M | Buy |
+1,376,393
| New | +$35.7M | 0.01% | 897 |
|